AzTrials
AzTrials

Appendicitis AcuteNCT04485247

Transumbilical Laparoscopy-assisted Appendectomy

A study testing Transumbilical Laparoscopic-Assisted Appendectomy and 3-port laparoscopic appendectomy in people with Appendicitis Acute, run by Myongji Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

transumbilical laparoscopic-assisted appendectomy (TULAA) was reported that the operation time was shorter and the postoperative frequency of complications was not high compared to conventional laparoscopic appendectomy (CLA) with three conventional ports in retrospective studies. Read more about this study

Who is it for?
Ages 1 year to 18 years
Conditions the study is for
Appendicitis Acute
What is being tested?
Transumbilical Laparoscopic-Assisted Appendectomy and 3-port laparoscopic appendectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
1 siteSouth Korea
Study dates
3 Aug 2020to Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients with clinically diagnosed as acute appendicitis
  • Age 18 or under
  • Lab tests Hemoglobin ≥ 10g/dl White blood cell count ≥ 4,000/mm3 Platelet count ≥ 100,000/mm3 Creatinine ≤ 1.5 mg/dl Aspartate aminotransferase ≤ 100 IU/L Alanine aminotransferase ≤ 100 IU/L
  • no significant dysfunction in the heart, lungs, kidneys.

Who cannot join

  • Previous abdominal operation
  • Generalized peritonitis
  • Anticipated extended resection
  • Periappendiceal abscess on preoperative exam

Trial locations and contacts

1 site in 1 country.

Kyung-Goo Lee, MD contact

+82-31-810-5445

hashimot@naver.com

South Korea1 site, 1 recruiting
  • Myongji Hospital, Hanyang university college of medicine

    Goyang-si, Gyeonggi-do, 412-826

    Kyung-Goo Lee, MD, +82-31-810-5445, hashimot@naver.com

    Recruiting

Other trials in South Korea

About this study

Official title: Is Transumbilical Laparoscopy-assisted Appendectomy in the Pediatric Acute Uncomplicated Appendicitis Superior to Conventional 3 Port Laparoscopic Appendectomy?

transumbilical laparoscopic-assisted appendectomy (TULAA) was reported that the operation time was shorter and the postoperative frequency of complications was not high compared to conventional laparoscopic appendectomy (CLA) with three conventional ports in retrospective studies. The purpose of this study is to evaluate the outcomes of transumbilical laparoscopic-assisted appendectomy (TULAA) and to compare them to the outcomes of CLA.

Read the detailed description

Single port appendectomy can be considered as the better option than conventional laparoscopic appendectomy (CLA) for pediatric patients with uncomplicated acute appendicitis in cosmetic aspect. However, this technique has not gained popularity because it has been regarded as a tricky and time-consuming procedure. Recently, the frequency of implementation of transumbilical laparoscopy-assisted appendectomy (TULAA) is increasing in pediatric patients with uncomplicated appendicitis. The reason that this operation is possible in children, is that the length between umbilicus and appendix is shorter than that of an adult, and the abdominal wall is flexible, so that the appendix can be extracted through umbilical incision. It was reported that the operation time was shorter and the postoperative frequency of complications was not high compared to the laparoscopic appendectomy with three conventional ports. The purpose of this study is to evaluate the outcomes of transumbilical laparoscopic-assisted appendectomy (TULAA) and to compare them to the outcomes of CLA.

Being tested
Transumbilical Laparoscopic-Assisted Appendectomy, 3-port laparoscopic appendectomy
Medical subject headings
Appendicitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transumbilical Laparoscopic-Assisted AppendectomyProcedure or surgery

    appendectomy performed extracorporeally through umbilical port

  • 3-port laparoscopic appendectomyProcedure or surgery

    appendectomy performed intracorporeally with 3-port

Study groups in NCT04485247
Study groupRoleWhat they receive
Conventional groupActive comparatorconventional laparoscopic appendectomy with 3-ports
Receives: Procedure: 3-port laparoscopic appendectomy
TULAA groupExperimentalAn operator extracts and ligates appendix through umbilical port.
Receives: Procedure: Transumbilical Laparoscopic-Assisted Appendectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Operation time

    Time from skin incision to skin closure

    Measured: 1 day

Secondary outcomes (2)
  1. Postoperative complication rate

    Rate of 30 day complication or in-hospital complication

    Measured: 1 month

  2. postoperative hospital stay

    postoperative hospital stay

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2020
  2. Study start3 Aug 2020
  3. Primary completionDec 2021 (estimated)
  4. Study completionMar 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04485247
Sponsor's protocol ID
Myongji Surgery
Status last verified
Aug 2020
First submitted
20 Jul 2020
Last updated
2 Sep 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all individual participant data that underlie results in a publication

Publications

  • Sekioka A, Takahashi T, Yamoto M, Miyake H, Fukumoto K, Nakaya K, Nomura A, Yamada Y, Urushihara N. Outcomes of Transumbilical Laparoscopic-Assisted Appendectomy and Conventional Laparoscopic Appendectomy for Acute Pediatric Appendicitis in a Single Institution. J Laparoendosc Adv Surg Tech A. 2018 Dec;28(12):1548-1552. doi: 10.1089/lap.2018.0306. Epub 2018 Aug 8.

    PubMed 30088968
  • Dubbers M, Nikolaou E, Fuchs H, Fischer J, Alakus H, Leers J, Bruns C, Cernaianu G. Update on Transumbilical Single-Incision Laparoscopic Assisted Appendectomy (TULAA) - Which Children Benefit and What are the Complications? Klin Padiatr. 2018 Jul;230(4):194-199. doi: 10.1055/s-0044-101622. Epub 2018 Mar 15.

    PubMed 29544230
  • Shekherdimian S, DeUgarte D. Transumbilical laparoscopic-assisted appendectomy: an extracorporeal single-incision alternative to conventional laparoscopic techniques. Am Surg. 2011 May;77(5):557-60. doi: 10.1177/000313481107700513.

    PubMed 21679587

Questions about this trial

What is this clinical trial studying?

A study testing Transumbilical Laparoscopic-Assisted Appendectomy and 3-port laparoscopic appendectomy in people with Appendicitis Acute, run by Myongji Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kyung-Goo Lee, MD (+82-31-810-5445, hashimot@naver.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Operation time (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04485247, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in